The Broad Institute of MIT and Harvard is a research organization that convenes a community of researchers from across many disciplines and partner institutions—MIT, Harvard, and Harvard-affiliated hospitals. Founded in 2004, it utilizes collaborative approaches to accelerate discoveries in biomedicine and improve human health.
2008
26-3428781
$2.728 billion
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Marking two decades of advancement in genomic medicine and research.
Converted clinical genetics lab into a COVID-19 testing facility in under two weeks.
Screened over 1,275 cancer cell lines to support cancer research.
Broad researchers visit classrooms to educate students on genetics.
Learn MoreOverall Score
71
48
/100
Program Expense Ratio
84.81%
16
/20
Program Revenue Growth
-41.20%
2
/20
Leverage Ratio
0.2818
12
/20
Working Capital Ratio
2.371
16
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2021
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 631.4M | 60.07% |
Program Services | 360.1M | 34.26% |
Investment Income | 2.073M | 0.20% |
Sales of Non-Inventory Assets | 41.1M | 3.91% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 1.051B | 100.00% |
Med Research
Hereditary Disease ResearchMed Research
Hereditary Disease ResearchMed Research
Hereditary Disease ResearchMed Research
Hereditary Disease ResearchMed Research
Hereditary Disease Research